Oaktree Acquisition Corp. III Life Sciences

Oaktree Acquisition Corp. III Life Sciences is a blank-check company sponsored by Oaktree Capital Management, the Los Angeles-based alternative investment firm recognized for its credit and alternative asset strategies. The vehicle's warrants trade under the ticker OACCW, and the SPAC carries a stated mandate focused on the life sciences sector. The company filed a Form 10-Q with the SEC on May 13, 2026 (accession number 0001193125-26-221814), its most recent quarterly disclosure, suggesting the vehicle remains active in its search phase. As Oaktree's third SPAC vehicle, it extends the firm's track record of sector-specific acquisition strategies. Sign up at SpacDesk for full financial data, filing history, and deal-tracking coverage on OACCW and hundreds of other active SPACs.